ARA named radiopharmaceutical 'center of excellence'

By staff writers

September 14, 2022 -- The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has certified ARA Diagnostic Imaging's ARA Theranostics Center as a radiopharmaceutical therapy center of excellence.

The theranostics center, which opened in 2021, offers prostate specific membrane antigen-based therapy for prostate cancer and peptide receptor radionuclide therapy.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking